Winning the new shape of demand will require targeting and appealing to each segment differently, rather than treating GLP-1 users as a single, homogeneous consumer group, says Lauren Taylor, a BCG managing director and senior partner who leads CCI globally
Available: [151] Johann Georg Sturm, "Leucojum aestivum Sturm48," Wikimedia Commons
Pomegranate Health does not accept insurance
Sisley S, Gutierrez-Aguilar R, Scott M, D'Alessio DA, Sandoval DA, and Seeley RJ
Epub 2022 Nov 2.PMID: 36322838 Semaglutide 2.4 mg once a week in adults with overweight or obesity , and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial.Lancet